Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Artelo Biosciences, Inc. (ARTL) had Non-Operating Income/Expense of $0.08M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.43M |
|
-- |
|
-- |
|
$2.50M |
|
$-2.50M |
|
|
Non-Operating Income/Expense |
$0.08M |
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.50M |
|
$-2.48M |
|
0.30M |
|
0.30M |
|
$-8.01 |
|
$-8.01 |
|
| Balance Sheet Financials | |
$4.37M |
|
-- |
|
$2.09M |
|
$6.46M |
|
$1.46M |
|
-- |
|
$0.01M |
|
$1.46M |
|
$5.00M |
|
$2.96M |
|
$5.00M |
|
0.47M |
|
| Cash Flow Statement Financials | |
$-6.22M |
|
-- |
|
$9.80M |
|
$0.60M |
|
$4.20M |
|
$3.60M |
|
$0.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-48.57% |
|
-82.05% |
|
-37.58% |
|
-48.57% |
|
$10.74 |
|
$-20.66 |
|
$-20.66 |
|